Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001123292-24-000280
Filing Date
2024-09-23
Accepted
2024-09-23 09:41:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3271
  Complete submission text file 0001123292-24-000280.txt   4970
Mailing Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110
Business Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110 416-737-7600
PORTAGE BIOTECH INC. (Subject) CIK: 0001095435 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 144 | Act: 33 | File No.: 001-40086 | Film No.: 241315011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AGEX THERAPEUTICS, INC., 1101 MARINA VILLAGE PARKWAY, SUITE 201 ALAMEDA CA 94501
Business Address
MINTZ STEVEN (Reporting) CIK: 0002008741 (see all company filings)

Type: 144